Literature DB >> 21867426

Human adipose-derived stem cells impair natural killer cell function and exhibit low susceptibility to natural killer-mediated lysis.

Olga DelaRosa1, Beatriz Sánchez-Correa, Sara Morgado, Cristina Ramírez, Borja del Río, Ramón Menta, Eleuterio Lombardo, Raquel Tarazona, Javier G Casado.   

Abstract

Human adipose-derived stem cells (hASCs) have been successfully used in treating numerous diseases. However, several aspects need to be considered, particularly in the context of allogeneic cell therapy. To better understand hASCs-host interactions, we studied the phenotype of hASCs and their modulatory effect on natural killer (NK) cells by using bone marrow-mesenchymal stem cells (hBM-MSCs) as a reference. The hASCs displayed a lower susceptibility to NK cell-mediated lysis and a lower expression of ligands for DNAM-1 when compared with hBM-MSCs. Moreover, here we demonstrated that hASCs and hBM-MSCs can modulate NK cells through the action of soluble factors such as indoleamine 2,3-dioxygenase. Altogether, these results suggest that for an adoptive cell therapy based on the transfer of allogeneic hASCs, the NK-hASCs crosstalk will not result in an immediate recognition of the transferred cells. Thus, hASCs may remain in the tissue long enough to balance the immune response before being cleared.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21867426      PMCID: PMC3353740          DOI: 10.1089/scd.2011.0139

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  55 in total

1.  Activation of host tissue trophic factors through JAK-STAT3 signaling: a mechanism of mesenchymal stem cell-mediated cardiac repair.

Authors:  Arsalan Shabbir; David Zisa; Huey Lin; Michalis Mastri; Gregory Roloff; Gen Suzuki; Techung Lee
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-09-17       Impact factor: 4.733

2.  Human prostasomes express CD48 and interfere with NK cell function.

Authors:  R Tarazona; E Delgado; M C Guarnizo; R G Roncero; S Morgado; B Sánchez-Correa; J J Gordillo; J Dejulián; J G Casado
Journal:  Immunobiology       Date:  2010-03-18       Impact factor: 3.144

3.  Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair.

Authors:  Xi-Ping Huang; Zhuo Sun; Yasuo Miyagi; Heather McDonald Kinkaid; Li Zhang; Richard D Weisel; Ren-Ke Li
Journal:  Circulation       Date:  2010-11-22       Impact factor: 29.690

4.  Mesenchymal stem cells fail to trigger effector functions of cytotoxic T lymphocytes.

Authors:  Ida Rasmusson; Michael Uhlin; Katarina Le Blanc; Victor Levitsky
Journal:  J Leukoc Biol       Date:  2007-07-03       Impact factor: 4.962

5.  Variation of human natural killer cell phenotypes with age: identification of a unique KLRG1-negative subset.

Authors:  Richard P G Hayhoe; Sian M Henson; Arne N Akbar; Donald B Palmer
Journal:  Hum Immunol       Date:  2010-04-23       Impact factor: 2.850

6.  Soluble factors from ASCs effectively direct control of chondrogenic fate.

Authors:  B-S Kim; K-S Kang; S-K Kang
Journal:  Cell Prolif       Date:  2010-06       Impact factor: 6.831

7.  Effects of human mesenchymal stem cells on the differentiation of dendritic cells from CD34+ cells.

Authors:  Lei Chen; Wei Zhang; Han Yue; Qin Han; Bin Chen; Mingxia Shi; Jing Li; Binzong Li; Shengguo You; Yufang Shi; Robert Chunhua Zhao
Journal:  Stem Cells Dev       Date:  2007-10       Impact factor: 3.272

8.  Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications.

Authors:  Soufiane Ghannam; Carine Bouffi; Farida Djouad; Christian Jorgensen; Danièle Noël
Journal:  Stem Cell Res Ther       Date:  2010-03-15       Impact factor: 6.832

9.  Using human adipose tissue-derived mesenchymal stem cells as salvage therapy for hepatic graft-versus-host disease resembling acute hepatitis.

Authors:  B Fang; Y Song; R C Zhao; Q Han; Q Lin
Journal:  Transplant Proc       Date:  2007-06       Impact factor: 1.066

10.  Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo.

Authors:  Alain J Poncelet; Jonathan Vercruysse; Alain Saliez; Pierre Gianello
Journal:  Transplantation       Date:  2007-03-27       Impact factor: 4.939

View more
  43 in total

1.  Human adipose-derived stromal/stem cells induce functional CD4+CD25+FoxP3+CD127- regulatory T cells under low oxygen culture conditions.

Authors:  Trivia P Frazier; James B McLachlan; Jeffrey M Gimble; Hugh A Tucker; Brian G Rowan
Journal:  Stem Cells Dev       Date:  2014-03-11       Impact factor: 3.272

Review 2.  Concise review: The obesity cancer paradigm: exploration of the interactions and crosstalk with adipose stem cells.

Authors:  Amy L Strong; Matthew E Burow; Jeffrey M Gimble; Bruce A Bunnell
Journal:  Stem Cells       Date:  2015-02       Impact factor: 6.277

Review 3.  Is Stem Cell Commerce in Small Animal Therapies Scientifically and Morally Justified?

Authors:  Luane Lopes Pinheiro; Ana Rita de Lima; Érika Branco
Journal:  Stem Cell Rev Rep       Date:  2019-08       Impact factor: 5.739

4.  Clinical-grade mesenchymal stromal cells produced under various good manufacturing practice processes differ in their immunomodulatory properties: standardization of immune quality controls.

Authors:  Cedric Menard; Luciano Pacelli; Giulio Bassi; Joelle Dulong; Francesco Bifari; Isabelle Bezier; Jasmina Zanoncello; Mario Ricciardi; Maelle Latour; Philippe Bourin; Hubert Schrezenmeier; Luc Sensebé; Karin Tarte; Mauro Krampera
Journal:  Stem Cells Dev       Date:  2013-02-25       Impact factor: 3.272

Review 5.  NK and MSCs crosstalk: the sense of immunomodulation and their sensitivity.

Authors:  Javier G Casado; R Tarazona; F M Sanchez-Margallo
Journal:  Stem Cell Rev Rep       Date:  2013-04       Impact factor: 5.739

6.  Mesenchymal stem cell and regenerative medicine: regeneration versus immunomodulatory challenges.

Authors:  Sujata Law; Samaresh Chaudhuri
Journal:  Am J Stem Cells       Date:  2013-03-08

7.  Engraftment potential of adipose tissue-derived human mesenchymal stem cells after transplantation in the fetal rabbit.

Authors:  Itziar Martínez-González; Rafael Moreno; Jordi Petriz; Eduard Gratacós; Josep M Aran
Journal:  Stem Cells Dev       Date:  2012-07-31       Impact factor: 3.272

8.  Bone Marrow Mesenchymal Stem Cells Combat Lipopolysaccharide-Induced Sepsis in Rats via Amendment of P38-MAPK Signaling Cascade.

Authors:  Omnia S Zaki; Marwa M Safar; Afaf A Ain-Shoka; Laila A Rashed
Journal:  Inflammation       Date:  2018-03       Impact factor: 4.092

9.  Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn's disease: results from a multicenter phase I/IIa clinical trial.

Authors:  F de la Portilla; F Alba; D García-Olmo; J M Herrerías; F X González; A Galindo
Journal:  Int J Colorectal Dis       Date:  2012-09-29       Impact factor: 2.571

Review 10.  Can mesenchymal stem cells be used to treat COVID-19-induced pneumonia? (Review).

Authors:  İdil Çetin; Mehmet Topçul
Journal:  Biomed Rep       Date:  2020-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.